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We have analyzed exon 9 of the WTI gene of 18 non-familial/sporadic unilateral Wilms’ tumors (WTs) from Japanese patients, by the polymerase 
chain reaction single-strand conformation polymorphism (PCR-SSCp3 method. After screening these WTs, a nucleotide alternation, which was 
present on both alleles, was found in only one case. Furthermore, PCR-SSCP analysis of the constitutional DNA revealed that this patient carried 
the mutation on only one allele in the germline. Sequence analysis showed that the tumor carried a point mutation (C-l 180 to T-l 180) in WTZ 
exon 9 of both alleles, resulting in an Arg-394 to Trp-394 amino acid substitution within the third zinc finger domain of the WTl product. 
Interestingly, this mutation is identical with the most frequent point mutation associated with the Denys-Drash syndrome. However, the classical 
triad of DenysDrash syndrome does not apply to this patient. This is in the first report of the point mutation in the zinc finger domain of both 
WTZ alleles in a sporadic unilateral WT without genitourinary abnormalities, and the mutation suggests that some sporadic WTs carry the 
Denys-Drash WTZ mutations. 
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1. INTRODUCTION 
Wilms’ tumor (WT) is an embryonal malignancy of 
the kidney arising from a metanephric blastoma [l]. The 
occurrence of both sporadic and hereditary forms of 
WT and the early age of bilateral WT onset suggest that 
WTs develop when a predisposing ermline mutation is 
accompanied by a second mutation [2]. A tumor sup- 
pressor gene for WT, WTl, has recently been isolated 
from the distal 11~13 region [3,4]. The WTI gene con- 
tains 10 coding exons that produce four distinct WTl 
mRNAs [5], and encodes a DNA-binding protein with 
a serine- and proline-rich NH, terminus and 4 zinc fin- 
gers [4]. These findings indicate that WTZ has several 
features characteristic of transcription factors and that 
WTl zinc finger domains can bind to a specific DNA 
sequence [4,6]. 
There are two disease syndromes in which a genetic 
predisposition to WT is observed, with similar genital 
system malformations. The first is WAGR syndrome 
(Wilms’ tumor (W), aniridia (A), genitourinary abnor- 
malities (G), and mental retardation (R) [7]; the second 
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is the Denys-Drash syndrome [8,9]. The latter is a syn- 
drome characterized by the association of nephropathy, 
dysgenetic male pseudohermaphroditism and WT. The 
nephropathy is characterized by its very early onset 
(before the age of 2 years), and in most patients it pro- 
gresses to chronic or end-stage renal failure within a few 
months to 2 years from the onset [lo]. From a morpho- 
logical point of view, the nephropathy is often charac- 
terized by a lesion described as diffuse mesangial sclero- 
sis [lo]. Recently, Pelletier et al. made a detailed analysis 
of the WTI gene in 10 Denys-Drash patients [l 11. They 
found point mutations in the WTl gene in all 10. Seven 
out of the 10 patients have a specific point mutation 
(C-l 180 to T) in exon 9 (zinc finger III). These findings 
indicate that WTI plays a direct role in the pathogenesis 
of the Denys-Drash syndrome [l 11. 
In this report, we present one case of a point mutation 
in WTZ exon 9 in a unilateral sporadic WT from a 
Japanese girl. Furthermore, the patient carries the mu- 
tation on one allele in the germline. Sequence analysis 
of WTI exon 9 revealed that the tumor has the same 
point mutation as that of WTs from the majority of 
Denys-Drash individuals. However, she has neither 
renal failure nor malformation of the external genitalia, 
and is alive and well at 7 years of age without renal 
failure. In these respects, the triad of the Denys-Drash 
syndrome does not apply to this patient. This is the first 
report of a point mutation of the zinc finger domain of 
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both WTZ alleles in a sporadic unilateral WT without 
genitourinary abnormalities [11,121, and the mutation 
suggests that some sporadic WTs carry the Denys- 
Drash WTZ mutations. 
2. MATERIALS AND METHODS 
2.1. Genomic DNA isolation 
Genomic DNAs were prepared from tumorous and normal kidneys 
of WT patients by the SDS-proteinase K method [13] with slight 
modification. Ground tissues were suspended in 100 mM ethylenedi- 
amine tetraacetic acid (EDTA), 0.5% sodium dodecyl sulfate (SDS), 
and 0.5 mg of RNase A per ml for 3 h at 37°C then incubated for 3 
h at 50°C with an additional 0.1 mg of proteinase K per ml. The DNA 
was extracted with phenol and chloroform, then precipitated with 
2-isopropyl alcohol. 
2.2. Polymerase chain reaction (PCR) amphjication 
The PCR was performed by using a DNA thermocycler (Perkin- 
Elmer-Cetus) with 0.1 pg of genomic DNA in a total volume of 10 ,ul. 
Thirty cycles of amplification were carried out (7 min at 94°C once, 
followed by 1 min at 94°C 1 min at 55°C and 1 min at 72°C for 30 
cycles, then 10 min at 72°C) with two pairs of prtmers (9A and 9S, 9a 
and 9s). Prior to the PCR, the primers were radiolabeled with T4 
polynucleotide kinase (Takara Biochemicals) and [y-3ZP]ATP. 
2.3. Single-strand conformation polymorphism (SSCP) gel analysis 
After the PCR reaction, the PCR products were diluted lo-fold in 
a solution containing 95% formamide, 20 mM EDTA, 0.05% bromo- 
phenol blue, and 0.05% xylene cyanol. The products were heated at 
90°C for 5 min and cooled on ice. The samples were loaded onto 5% 
nondenaturing polyacrylamide gels (49:l polyacrylamide/methylene 
bis-acrylamide) containing 1 x TBE (90 mM Tris-borate pH 8.3,2 mM 
EDTA) and 5% glycerol. Electrophoresis was carried out at 40-W 
constant power at room temperature in an electrophorical apparatus 
(Bio-Rad, Model 3000Xi). The gel was dried on filter paper and 
exposed to X-ray film at -70°C for 12 h. 
2.4. DNA sequencing 
The PCR products were sequenced by the linear PCR method [14]. 
Briefly, one pmol of the primer was 5’-end-labeled in 20 ~1 of a 
reaction mixture containing 60 mM Tris-HCl (pH 7.5) 9 mM MgCL, 
10 mM DTT, 2 U of T,polynucleotide kinase (Takara Biochemicals), 
and 5 PCi of [y-32P]ATP for 20 min at 37°C. One ~1 of this reaction 
mixture was added to a mixture of 16.6 mM (NH&SO,, 67 mM 
Tris-HC1 (pH 8.8), 6.7 mM MgCl,, 10 mM DTT, 2 mg of BSA per 
ml, 2.5 PM each of dATP, dCTP, dGTP, dTTP, 0.6 unit of Taq DNA 
polymerase (Perkin-Elmer-Cetus), and either 1 mM ddT, 50pM ddG, 
500 PM ddA or 500 PM ddC (final volume 20 ~1) and the solution was 
overlaid with 50 ~1 of mineral oil. Thirty cycles of PCR were carried 
out at 95°C (1 min), 45°C (1 min) and 72°C (2 min). Two ~1 of each 
mixture was loaded on a 6% polyacrylamide-urea sequencing gel. 
3. RESULTS 
3.1. Detection of mutations on WTl exon 9 in sporadic 
WTs 
The PCR-SSCP method [15] was used to screen for 
mutations in WTl exon 9 (zinc finger domain III) of 
DNAs extracted from 18 sporadic unilateral WTs. 
Table I summarizes the clinical and pathological data 
of the 18 patients. None of these patients presented with 
genital malformations, and 16 of the 18 tumors were 
histologically diagnosed as triphasic nephroblastoma 
[16]. By Southern blot analysis, we did not detect any 
40 
gross deletion or DNA rearrangement within the WTZ 
gene in any of the 18 WTs. Therefore, we examined the 
WTs for small nucleotide changes in WTl exon 9 by the 
PCR-SSCP method using specific primers (9A and 9s) 
designed by Pelletier et al. (Table II) [ll]. Primer 9a, 
which contains a mutated base against primer 9A, is 
used with 9S to show that a point mutation can be 
detected under our PCR-SSCP conditions. The SSCP 
pattern in Fig. 1A clearly indicates that the point-mu- 
tated WTI gene can be distinguished from the normal 
WTZ gene by mobility shift. None of the PCR products 
from 17 WTs and the control human placenta showed 
a mobility shift, indicating no structural alteration. The 
only exception was a fragment resulting from case 12 
(Fig. 1B). 
3.2. SSCP analysis of WTl in a germline of a patient 
We analyzed the WTl gene in the constitutional 
DNA to determine whether gerrnline mutation could 
occur in this patients (case 12). Fig. 1B shows the PCR- 
SSCP analysis of the WTZ exon 9 in the normal kidney 
of the patient. The SSCP pattern in Fig. IB indicates 
that the WT of this patient carries the mutation in exon 
9 of both WTl alleles, and that the patient carries the 
same mutation of one WTZ allele in the germline. 
3.3. Sequence analysis of the WTl gene in WTfrom the 
same patient 
To elucidate the structural change in WTZ exon 9 
from WT of this patient, we subjected the PCR product 
to direct sequencing. The results shown in Fig. 2 re- 
vealed a cytosine-1180 (C) to thymine- (T) transi- 
tion in exon 9 of both WTl alleles. This mutation results 
Table I 
Clinical information and histology of 18 unilateral WTs 
Case Age(yr/mo) Sex Histology Abnormality* 
1 o/2 F NBW, triphasic 
2 016 M NBW, triphasic 
3 114 M NBW, triphasic 
4 l/4 M NBW, triphasic 
5 l/4 M NBW. triphasrc 
6 l/4 F NBW, triphasic 
7 l/5 F NBW. triphasic 
8 l/6 F NBW. trtphastc 
9 2/o M NBW, triphasic 
10 2/l F NBW, triphasic 
11 2/l M NBW, triphasic 
12 216 F NBW, triphasic a point mutation 
13 3/o F NBW, triphasic 
14 312 F NBW, triphasic 
15 3/8 F NBW. CPDN 
16 4/o F NBW, Mesenchymal 
17 412 M NBW, triphasic 
18 412 M NBW, triphasic 
NBW, nephroblastic Wilms’ tumor; CPDN, cystic partially differenti- 
ated nephroblastoma. 
*Abnormality detected by PCR-SSCP analysis 
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in the conversion of arginine-394 (Arg) to tryptophane- 
394 (Trp) within the third zinc finger domain of the 
WTZ product. Interestingly, this mutation is identical 
with the most frequent point mutation, as described by 
Pelletier et al. [II], associated with the Denys-Drash 
syndrome. 
3.4. Patient and pathological observation 
The patient (case 12) was a girl who was 2 l/2 years 
old at the time of the operation. The tumor arose in the 
upper portion of her right kidney. Thorough computer- 
ized tomography, X-ray and echo examinations re- 
vealed no evidence of a tumor in her left kidney. There 
was no family history of a renal tumor. She did not 
present with nephropathy (proteinuria/elevated serum 
creatinine). Furthermore, she had normal female exter- 
nal genitalia, and had no other abnormalities such as 
aniridia and mental retardation. After nephrectomy of 
the tumorous kidney, she is alive and well at the age of 
7 years without renal failure. On histopathological ex- 
amination, the WT of this patient showed an admixture 
of three components (epithelial, stromal and blastemal), 
indicating that the tumor was of the nephroblastic, 
triphasic type [ 161. Furthermore, histological examina- 
tion of the renal tissue adjacent o the tumor showed no 
apparent features of diffuse mesangial sclerosis which 
are considered to be the specific histology of the Denys- 
Drash syndrome (Fig. 3) [IO]. 
4. DISCUSSION 
The incidence of gross genomic alteration of WTZ in 
WTs is very low [4,17-201. Our previous study also 
revealed only three partial deletions, which include one 
case of an intragenic deletion, in 25 unilateral sporadic 
WTs [21]. Therefore, investigations detecting more sub- 
tle DNA abnormalities uch as small deletions or point 
mutations is required to understand the role of the WTI 
gene in the development of WT. 
Since subtle DNA abnormalities in the zinc finger 
domains of the WTl gene have been shown to affect 
DNA binding [6], we reasoned that such DNA abnor- 
malities in the WTZ zinc finger may occur and contrib- 
ute to the tumorigenesis in sporadic unilateral WTs. 
Therefore, we chose to search unilateral WTs for subtle 
DNA abnormalities in the WTZ zinc finger by the PCR- 
SSCP method. In this paper, we have described one case 
of a point mutation in WTZ exon 9 in a unilateral 
Table II 
Primers for PCR-SSCP of WTI exon 9 
Name Sequence 
9A 5'-CCCCGAATTCAAGATAGCCACGCACTATTCC-3' 
9a 5'-CCCCGAATTCAAGATAGCCAEGCACTATTCC-3‘ 
9s 5'-CCCCAAGCTTCAGGAAATGCTGGGCTCC-3' 
A 1 2 
Fig. 1. (A) PCR-SSCP patterns obtained from the control unaffected 
human placental DNA. Genomic DNAs were subjected to PCR-SSCP 
analysis with two pairs of primers (lane 1, 9A and 9s; lane 2, 9a and 
9s) flanking exon 9 of the WTJ gene. Primer 9a contains the mutated 
base (replacement of C [underlined] by T [underlined] in the primer 
9A). as indicated in Table II. (B) PCR-SSCP analysis of WTJ exon 
9. Genomic DNAs were isolated from WT of case 12 (lane l), normal 
kidney of case 12 (lane 2) and unaffected normal human placenta (lane 
3), and subjected to PCR-SSCP analysis with a pair of primers (9A 
and 9s). The separated strands of fragment (lane 1) from WT moved 
to downward positions from the control human placenta (lane 3). 
Moreover, we could not detect any fragment in WT with the same 
mobility as that of the fragments from the control. In lane 2, the 
amplified fragments from normal kidney of case 12 were separated 
into four single-stranded DNAs. In four strands, two out of them had 
the same mobility as that from the unaffected normal human placenta, 
and the other two had the same mobility as that of the fragment from 
WT of this patient (lane 1). Electrophoresis was carried out in 5% 
polyacrylamide gel with 5% glycerol at room temperature. 
sporadic WT, and this is the first report of the point 
mutation in the zinc finger domain of both WTl alleles 
in a sporadic WT without genitourinary abnormalities 
[11,12]. 
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Fig. 2. Nucleotide sequence analysis of PCR products obtained from WT of case 12 were sequenced as described in section 2. The arrowhead 
represents the site of the point mutation (replacement of C by T). 
Sequence analysis revealed that the point mutation in 
this patient is identical with the most frequent point 
mutation in the Denys-Drash syndrome [ 111. However, 
clinically, the Denys-Drash syndrome could not apply 
to this patient in terms of nephropathy [lo]. In the study 
of 10 Denys-Drash patients, seven cases of nephropa- 
thy with WT were found [ll]. Interestingly, six of the 
seven cases had the common point mutation in exon 9 
of one WTZ allele in the germline. Those authors postu- 
lated that the germline hemizygous inactivation of WTI 
contributes to the development of apparently non-WT- 
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associated genitourinary abnormalities [11,22,23]. Our 
patient carries the same point mutation as that of the 
above cases in the germline. However, their model does 
not apply to our case since the nephropathy associated 
with this syndrome has not occurred in this patient. 
Why is the effect of such a hemizygous mutation abro- 
gated in this patient? One possible explanation is that 
the renal failure may be caused by a truncated form of 
the WTl gene product [24]. Another possible explana- 
tion is the influence of other genetic or environmental 
factors. Although there have been o reported cases 
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Fig. 3. Microscopic observation of the normal kidney of case 12. The histology of the renal tissue adjacent o WT did not show the apparent features 
of diffuse mesangial sclerosis which is considered to be a specific histology for the Denys-Drash syndrome. 
which are parallel to this one, this discrepancy will be 
clarified by detailed analysis after accumulation of cases 
like this one. 
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